|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | G01N 33/574 |
| (11) | Patento numeris | 2596363 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11746191.3 |
| Europos patento paraiškos padavimo data | 2011-07-18 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-01-18 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/062232 |
| Data | 2011-07-18 |
| (87) | Numeris | WO 2012/010552 |
| Data | 2012-01-26 |
| (30) | Numeris | Data | Šalis |
| 10170008 | 2010-07-19 | EP |
| (72) |
DE HAAS, Sanne Lysbet, CH
DELMAR, Paul, CH
FOERNZLER, Dorothee, CH
KLAUSE, Ursula, DE
SCHERER, Stefan, US
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER |
| BLOOD PLASMA BIOMARKERS FOR BEVACIZUMAB COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER |